BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 19460479)

  • 1. [Anemia in chronic kidney disease and its cardiovascular implications].
    Cases A; Coll E; Collado S
    Med Clin (Barc); 2009 May; 132 Suppl 1():38-42. PubMed ID: 19460479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing a fateful alliance: anaemia and cardiovascular outcomes.
    Eckardt KU
    Nephrol Dial Transplant; 2005 Jun; 20 Suppl 6():vi16-20. PubMed ID: 15958821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment anaemia of chronic kidney disease in predialysis patients (stage 1-4)].
    Lovcić V; Vujić J; Ivanac Janković R; Basić-Jukić N; Barisić I; Lovcić P; Dzapo M
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():11-6. PubMed ID: 20232547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Erythropoesis-stimulating agents: past, present and future].
    Kes P; Basić-Jukić N
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():3-6. PubMed ID: 20235351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anemia and the heart in chronic kidney disease.
    Zalunardo N; Levin A
    Semin Nephrol; 2006 Jul; 26(4):290-5. PubMed ID: 16949467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anemia and cardiovascular risk: the lesson of the CREATE Trial.
    Locatelli F; Del Vecchio L; Pozzoni P
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S262-6. PubMed ID: 17130272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deadly triangle of anemia, renal insufficiency, and cardiovascular disease: implications for prognosis and treatment.
    McCullough PA; Lepor NE
    Rev Cardiovasc Med; 2005; 6(1):1-10. PubMed ID: 15741920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regarding the optimal hemoglobin target range in renal anemia].
    Maurin N
    Med Klin (Munich); 2008 Sep; 103(9):633-7. PubMed ID: 18813886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia and cardiovascular risk in the patient with kidney disease.
    Fishbane S
    Heart Fail Clin; 2008 Oct; 4(4):401-10. PubMed ID: 18760752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piecing together the evidence on anemia: the link between chronic kidney disease and cardiovascular disease.
    McCullough PA; Lepor NE
    Rev Cardiovasc Med; 2005; 6 Suppl 3():S4-12. PubMed ID: 16340933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating anemia at different stages of renal disease.
    Locatelli F; Del Vecchio L; Pozzoni P
    J Nephrol; 2007; 20 Suppl 12():S33-8. PubMed ID: 18050140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoiesis-stimulating agents, hypertension and left ventricular hypertrophy in the chronic kidney disease patient.
    Schmid H; Schiffl H; Lederer SR
    Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):465-70. PubMed ID: 21738032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal anaemia: recent developments, innovative approaches and future directions for improved management.
    Kerr PG
    Nephrology (Carlton); 2006 Dec; 11(6):542-8. PubMed ID: 17199795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia in renal disease: diagnosis and management.
    Lankhorst CE; Wish JB
    Blood Rev; 2010 Jan; 24(1):39-47. PubMed ID: 19833421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anemia as a risk factor for CKD and CVD].
    Tsuruya K; Hirakata H
    Nihon Rinsho; 2008 Sep; 66(9):1786-93. PubMed ID: 18788410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality?
    Abaterusso C; Pertica N; Lupo A; Ortalda V; Gambaro G
    Diabetes Obes Metab; 2008 Sep; 10(10):843-9. PubMed ID: 18093210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TREAT or not to treat: anemia in type 2 diabetes and chronic kidney disease at stages 3 and 4].
    Choukroun G; Renou M; Lecaque C; Jauréguy M
    Nephrol Ther; 2011 Feb; 7(1):2-9. PubMed ID: 21216683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Tonelli M; Garg AX; Pellegrini F; Ravani P; Jardine M; Perkovic V; Graziano G; McGee R; Nicolucci A; Tognoni G; Strippoli GF
    Ann Intern Med; 2010 Jul; 153(1):23-33. PubMed ID: 20439566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.